Skip to main content
SpringerLink
Log in

Noninfectious Scleritis

  • Chapter
  • First Online:
The Sclera

Abstract

Because scleritis may occur in association with a variety of noninfectious local and systemic disorders (autoimmune, dermatological, metabolic, and foreign body reactions), its presence must be regarded in relation to the larger picture of a patient’s general health. Scleritis is frequently seen in association with autoimmune vasculitic diseases that affect predominantly small- and medium-sized vessels, such as rheumatoid arthritis, granulomatosis with polyangiitis (Wegener), relapsing polychondritis, arthritis and inflammatory bowel disease, systemic lupus erythematosus, polyarteritis nodosa, psoriatic arthritis, Behçet’s disease, or Cogan’s disease; scleritis is less commonly found in association with autoimmune vasculitic diseases that affect predominantly large-sized arteries, such as reactive arthritis, ankylosing spondylitis, or giant-cell arteritis. Scleritis may also be associated with other diseases, such as atopy, rosacea, gout, or local foreign body reactions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Harris ED. Rheumatoid arthritis: the clinical spectrum. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of rheumatology. 3rd ed. Philadelphia: W.B. Saunders Company; 1989.

    Google Scholar 

  2. Fleming A, Benn RT, Corbett M, et al. Early rheumatoid disease. II. Patterns of joint involvement. Ann Rheum Dis. 1976;35:361.

    PubMed  CAS  Google Scholar 

  3. Hull S, Mathews JA. Pulmonary necrobiotic nodules as a presenting feature of rheumatoid arthritis. Ann Rheum Dis. 1982;41:21.

    PubMed  CAS  Google Scholar 

  4. Hurd ER. Extra-articular manifestations of rheumatoid arthritis. Semin Rheum Dis. 1979;8:151.

    CAS  Google Scholar 

  5. Hart FD. Rheumatoid arthritis. Extra-articular manifestations. Br Med J. 1969;3:131.

    PubMed  CAS  Google Scholar 

  6. Nepom GT, Byers P, Seyfried C, et al. HLA genes associated with rheumatoid arthritis: identification of susceptibility alleles using specific oligonucleotide probes. Artritis Rheum. 1989;32:15.

    CAS  Google Scholar 

  7. Jacoby RK, Jayson MIV, Cosh JA. Onset, early stages and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11 year follow-up. Br Med J. 1973;2:96.

    PubMed  CAS  Google Scholar 

  8. Fleming A, Crown JM, Corbett M. Early rheumatoid disease. I. Onset. Ann Rheum Dis. 1976;35:357.

    PubMed  CAS  Google Scholar 

  9. Sharp JT, Calkins E, Cohen AS, et al. Observations on the clinical, chemical, and serologic manifestations of rheumatoid arthritis based on the course of 154 patients. Medicine. 1964;43:41.

    PubMed  CAS  Google Scholar 

  10. Masi AT, Maldonado-Cocco JA, Kaplan SB, et al. Prospective study of the early course of rheumatoid arthritis in young adults: comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome. Semin Arthritis Rheum. 1976;5:299.

    Google Scholar 

  11. Talbott JH, Altman RD, Yu TF. Gouty arthritis masquerading as rheumatoid arthritis or viceversa. Semin Arthritis Rheum. 1978;8:77.

    PubMed  CAS  Google Scholar 

  12. Khachadurian AK. Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia). Arthritis Rheum. 1968;2:385.

    Google Scholar 

  13. Wiernik PH. Amyloid joint disease. Medicine (Baltimore). 1971;51:465.

    Google Scholar 

  14. Gordon DA, Pruzanski W, Ogyzlo MA, Little HA. Amyloid arhritis simulating rheumatoid disease in five patients with multiple myeloma. Am J Med. 1973;55:142.

    PubMed  CAS  Google Scholar 

  15. Healey LA, Wilske KR, Sagebiel RW. Rheumatoid nodules simulating basal-cell carcinoma. N Engl J Med. 1967;277:7.

    PubMed  CAS  Google Scholar 

  16. Wood MG, Beerman H. Necrobiosis lipoidica, granuloma anulare. Report of a case with lesions in the galea aponeurotica of a child. Am J Dis Child. 1958;96:720.

    Google Scholar 

  17. Hahn BH, Yardley JH, Stevens MB. “Rheumatoid” nodules in systemic lupus erythematosus. Ann Intern Med. 1970;72:49.

    PubMed  CAS  Google Scholar 

  18. Dubois EL, Friou GJ, Chandor S. Rheumatoid nodules and rheumatoid granulomas in systemic lupus erythematosus. JAMA. 1972;220:515.

    PubMed  CAS  Google Scholar 

  19. Barrow MV, Holubar K. Multicentric reticulohistiocytosis: a review of 33 patients. Medicine (Baltimore). 1969;48:287.

    CAS  Google Scholar 

  20. Cats A, Hazevoet HM. Significance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. Ann Rheum Dis. 1970;29:254.

    PubMed  CAS  Google Scholar 

  21. Mongan ES, Cass RM, Jacox RF, Vaughan JH. A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis. Am J Med. 1969;47:23.

    PubMed  CAS  Google Scholar 

  22. Turner R, Collins R, Nomeir AM. Extraarticular manifestations of rheumatoid arthritis. Bull Rheum Dis. 1978–1979;29:986.

    Google Scholar 

  23. Sokoloff L, Bunim JJ. Vascular lesions in rheumatoid arthritis. J Chron Dis. 1957;5:668.

    PubMed  CAS  Google Scholar 

  24. Duthie JJR, Brown PE, Truelove LH, et al. Course and prognosis in rheumatoid arthritis. A further report. Ann Rheum Dis. 1964;23:193.

    PubMed  CAS  Google Scholar 

  25. Ragan C, Farrington E. The clinical features of rheumatoid arthritis. JAMA. 1962;181:663.

    PubMed  CAS  Google Scholar 

  26. Scott JT, Hourhane DO, Doyle FH, et al. Digital arteritis in rheumatoid disease. Ann Rheum Dis. 1961;20:224.

    PubMed  CAS  Google Scholar 

  27. Schmid FR, Cooper NS, Ziff M, et al. Arteritis in rheumatoid arthritis. Am J Med. 1961;30:56.

    PubMed  CAS  Google Scholar 

  28. Bienenstock H, Minick R, Rogoff B. Mesenteric arteritis and intestinal infarction in rheumatoid disease. Arch Intern Med. 1967;119:359.

    PubMed  CAS  Google Scholar 

  29. Voyles WF, Searles RP, Bankhurst AD. Myocardial infarction caused by rheumatoid vasculitis. Arthritis Rheum. 1980;23(7):860.

    PubMed  CAS  Google Scholar 

  30. Fong LP, Sainz de la Maza M, Rice BA, et al. Immunopathology of scleritis. Ophthalmology. 1991;98:472.

    PubMed  CAS  Google Scholar 

  31. Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore). 1981;60(4):288.

    CAS  Google Scholar 

  32. Scott DGI, Bacon PA, Allen C, et al. IgG rheumatoid factor, complement, and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol. 1981;43:54.

    PubMed  CAS  Google Scholar 

  33. Hunder GG, McDuffie FC. Hypocomplementinemia in rheumatoid arthritis. Am J Med. 1973;54:461.

    PubMed  CAS  Google Scholar 

  34. Scott DG, Baron PA, Elliot PJ, et al. Systemic vasculitis in a district general hospital 1972–80. Quart J Med. 1982;51:292.

    PubMed  CAS  Google Scholar 

  35. Ferguson RH, Slocumb CH. Peripheral neuropathy in rheumatoid arthritis. Bull Rheum Dis. 1961;11:251.

    PubMed  CAS  Google Scholar 

  36. Walker WC, Wright V. Pulmonary lesions and rheumatoid arthritis. Medicine. 1968;47:501.

    PubMed  CAS  Google Scholar 

  37. Dodson WH, Hollingsworth JW. Pleural effusion in rheumatoid arthritis: impaired transport of glucose. N Engl J Med. 1966;275:1337.

    PubMed  CAS  Google Scholar 

  38. Jones SJ. An account of pleural effusions, pulmonary nodules and cavities in rheumatic disease. Br J Dis Chest. 1978;72:39.

    PubMed  CAS  Google Scholar 

  39. Portner MM, Gracie WA. Rheumatoid lung disease with cavitary nodules, pneumothorax and eosinophilia. N Engl J Med. 1966;275:697.

    PubMed  CAS  Google Scholar 

  40. Brannan HM, Good CA, Divertie MB, et al. Pulmonary disease associated with rheumatoid arthritis. J Am Med Assoc. 1964;189:914.

    CAS  Google Scholar 

  41. Dixon AS, Ball J. Honeycomb lung and chronic rheumatoid arthritis: a case report. Ann Rheum Dis. 1957;16:241.

    PubMed  CAS  Google Scholar 

  42. Stack BHR, Grant IWB. Rheumatoid interstitial lung disease. Br J Dis Chest. 1965;59:202.

    PubMed  CAS  Google Scholar 

  43. Walker WC, Wright V. Diffuse interstitial pulmonary fibrosis and rheumatoid arthritis. Ann Rheum Dis. 1969;28:252.

    PubMed  CAS  Google Scholar 

  44. Frank ST, Weg JG, Harkleroad LE, et al. Pulmonary dysfunction in rheumatoid disease. Chest. 1973; 63:27.

    PubMed  CAS  Google Scholar 

  45. Caplan A. Certain unusual radiographic appearances in the chest of coal miners suffering from RA. Thorax. 1953;8:29.

    PubMed  CAS  Google Scholar 

  46. Caplan A, Cowen EDH, Gough J. Rheumatoid pneumoconiosis in a foundry worker. Thorax. 1958;13:181.

    PubMed  CAS  Google Scholar 

  47. Chatgidakis CB, Theron C. Rheumatoid pneumoconiosis (Caplan’s syndrome): a discussion of the disease and a report of a case in a European Witwatersrand gold miner. Arch Environ Health. 1961;2:397.

    PubMed  CAS  Google Scholar 

  48. Walker WC. Pulmonary infections and rheumatoid arthritis. Quart J Med. 1967;36:239.

    PubMed  CAS  Google Scholar 

  49. Catheart ES, Spodick DH. Rheumatoid heart disease: a study of the incidence and nature of cardiac lesions in rheumatoid arthritis. JAMA. 1962;266:959.

    Google Scholar 

  50. Bongiglio T, Atwater EC. Heart disease in patients with seropositive rheumatoid arthritis: a controlled autopsy study and review. Arch Intern Med. 1969;124:714.

    Google Scholar 

  51. Cosh JA. Arthritis and the heart. Bristol Med Chir J. 1969;84:145.

    PubMed  CAS  Google Scholar 

  52. Comess KA, Fenster PE, Gall EP. Cardiac involvement in rheumatoid arthritis. Cardiovasc Res. 1982;3:533.

    Google Scholar 

  53. Lie JT. Rheumatoid arthritis and heart disease. Primary Cardiol. 1982;40:137.

    Google Scholar 

  54. Kirk J, Cosh J. The pericarditis of rheumatoid arthritis. Quart J Med. 1969;38:397.

    PubMed  CAS  Google Scholar 

  55. Bacon PA, Gibson DG. Cardiac involvement in rheumatoid arthritis – an echocardiographic study. Ann Rheum Dis. 1972;31:426.

    PubMed  CAS  Google Scholar 

  56. MacDonald WJ, Crawford MH, Klippel JH, et al. Echocardiographic assessment of cardiac structure and function in patients with rheumatoid arthritis. Am J Med. 1977;63:890.

    PubMed  Google Scholar 

  57. Butman S, Espinoza LR, DelCarpio J, et al. Rheumatoid pericarditis: rapid deterioration with evidence of local vasculitis. JAMA. 1977;238:2394.

    PubMed  CAS  Google Scholar 

  58. Franco AE, Levine HO, Hall AP. Rheumatoid pericarditis: report of 17 cases diagnosed clinically. Ann Intern Med. 1972;77:837.

    PubMed  CAS  Google Scholar 

  59. Khan AH, Spodick DH. Rheumatoid heart disease. Semin Arthritis Rheum. 1972;1:327.

    PubMed  CAS  Google Scholar 

  60. Sokoloff L. The heart in rheumatoid arthritis. Am Heart J. 1953;45:635.

    PubMed  CAS  Google Scholar 

  61. Leibowitz WB. The heart in rheumatoid arthritis. Ann Intern Med. 1963;58:102.

    Google Scholar 

  62. Harris M. Rheumatoid heart disease with complete heart block. J Clin Pathol. 1970;23:623.

    PubMed  CAS  Google Scholar 

  63. Hoffman FG, Leight L. Complete atrioventricular block associated with rheumaoid disease. Am J Cardiol. 1965;16:585.

    PubMed  CAS  Google Scholar 

  64. Roberts WC, Kehoe JA, Carpenter DF, et al. Cardiac valvular lesions in rheumatoid arthritis. Arch Intern Med. 1968;122:141.

    PubMed  CAS  Google Scholar 

  65. Cruickshank B. Heart lesions in rheumatoid disease. J Pathol Bacteriol. 1958;76:223.

    PubMed  CAS  Google Scholar 

  66. Goehrs HR, Baggenstoss AH, Slocumb CH. Cardiac lesions in rheumatoid arthritis. Arthritis Rheum. 1960;3:298.

    PubMed  CAS  Google Scholar 

  67. Roberts WC, Dangel JC, Buklay BH. Non-rheumatic valvular cardiac disease: a clinicopathologic survey of 27 different conditions causing valvular dysfunction. Cardiovasc Clin. 1973;5:333.

    PubMed  CAS  Google Scholar 

  68. Reimer KA, Rodgers RF, Oyasu R. Rheumatoid arthritis with rheumatoid heart disease and granulomatous aortitis. JAMA. 1976;235:2510.

    PubMed  CAS  Google Scholar 

  69. Bywaters EGL. The relation between heart and joint disease including “rheumatoid heart disease” and chronic postrheumatic arthritis (type Jaccoud). Br Heart J. 1950;12:101.

    PubMed  CAS  Google Scholar 

  70. Karten I. Arteritis, myocardial infarction and rheumatoid arthritis. JAMA. 1969;210:1717.

    PubMed  CAS  Google Scholar 

  71. Parrillo JE, Fauci AS. Necrotizing vasculitis, coronary angiitis and the cardiologist. Am Heart J. 1980;99:547.

    PubMed  CAS  Google Scholar 

  72. Sweezy RL. Myocardial infarction due to rheumatoid arteritis. JAMA. 1967;199:855.

    Google Scholar 

  73. Chamberlain MA, Bruckner FE. Rheumatoid neuropathy: clinical and electrophysiological features. Ann Rheum Dis. 1970;29:609.

    PubMed  CAS  Google Scholar 

  74. Weller RO, Bruckner FE, Chamberlain MA. Rheumatoid neuropathy: a histological and electrophysiological study. J Neurol Neurosurg Psychiatry. 1970;33:592.

    PubMed  CAS  Google Scholar 

  75. Irby R, Adams RA, Toone EC. Peripheral neuritis associated with rheumatoid arthritis. Arthritis Rheum. 1958;1:44.

    PubMed  CAS  Google Scholar 

  76. Pallis CA, Scott JT. Peripheral neuropathy in rheumatoid arthritis. Br Med J. 1965;1:1141.

    PubMed  CAS  Google Scholar 

  77. Motulsky AG, Weinberg S, Saphir O, et al. Lymph nodes in rheumatoid arthritis. Arch Intern Med. 1952;90:660.

    CAS  Google Scholar 

  78. Nosanshuk JS, Schnitzer B. Follicular hyperplasia in lymph ` nodes from patients with rheumatoid arthritis. Cancer. 1969;24:343.

    Google Scholar 

  79. Robertson MDJ, Hart FD, White WF, et al. Rheumatoid lymphadenopathy. Ann Rheum Dis. 1968;27:153.

    Google Scholar 

  80. Kassan SS, Hoover R, Kimberly RP. Increased incidence of malignancy in Sjögren’s syndrome. Arthritis Rheum. 1977;20:123.

    Google Scholar 

  81. Whaley K, Webb J, McAvoy BA, et al. Sjögren’s syndrome. 2. Clinical associations and immunological phenomena. Quart J Med. 1973;42:513.

    PubMed  CAS  Google Scholar 

  82. Felty AR. Chronic arthritis in the adult, associated with splenomegaly and leucopenia. Johns Hopkins Hosp Bull. 1924;35:16.

    Google Scholar 

  83. Ruderman M, Miller LM, Pinals RS. Clinical and serologic observations on 27 patients with Felty’s syndrome. Arthritis Rheum. 1968;11:377.

    PubMed  CAS  Google Scholar 

  84. Sienknecht CW, Urowitz MB, Pruzanski W, et al. Felty’s syndrome. Clinical and serological analysis of 34 cases. Ann Rheum Dis. 1977;36:500.

    PubMed  CAS  Google Scholar 

  85. Hurd ER, Andreis M, Ziff M. Phagocytosis of immune complexes by polymorphonuclear leucocytes in patients with Felty’s syndrome. Clin Exp Immunol. 1977;28:413.

    PubMed  CAS  Google Scholar 

  86. Joyce RA, Boggs DR, Chervenick PA, et al. Neutrophil kinetics in Felty’s syndrome. Am J Med. 1980;69:695.

    PubMed  CAS  Google Scholar 

  87. Howe GB, Fordham JN, Brown KA, et al. Polymorphonuclear cell function in rheumatoid arthritis and in Felty’s syndrome. Ann Rheum Dis. 1981;40:370.

    PubMed  CAS  Google Scholar 

  88. Gupta RC, Laforce FM, Mills DM. Polymorphonuclear leukocyte inclusions and impaired bacterial killing in patients with Felty’s syndrome. J Lab Clin Med. 1976;88:183.

    PubMed  CAS  Google Scholar 

  89. Laszlo J, Jones R, Silberman HR, et al. Splenectomy for Felty’s syndrome: clinicopathological study of 27 patients. Arch Intern Med. 1978;138:597.

    PubMed  CAS  Google Scholar 

  90. Goldberg J, Pinals RS. Felty’s syndrome. Semin Arthritis Rheum. 1980;10:52.

    PubMed  CAS  Google Scholar 

  91. Cohen AS. Amyloidosis associated with rheumatoid arthritis. Med Clin North Am. 1968;52:643.

    PubMed  CAS  Google Scholar 

  92. Husby G. Amyloidosis in rheumatoid arthritis. Ann Clin Res. 1975;7:154.

    PubMed  CAS  Google Scholar 

  93. Arapakis G, Tribe CR. Amyloidosis in rheumatoid arthritis investigated by means of rectal biopsy. Ann Rheum Dis. 1963;22:256.

    PubMed  CAS  Google Scholar 

  94. Trieger N, Cohen AS, Calkins E. Gingival biopsy as a diagnostic aid in amyloid disease. Arch Oral Biol. 1959;1:187.

    Google Scholar 

  95. Falcek HM, Törnroth T, Skrifvars B, et al. Resolution of renal amyloidosis secondary to rheumatoid arthritis. Acta Med Scand. 1979;205:651.

    Google Scholar 

  96. Fernandes L, Sullivan S, McFarlane IG, et al. Studies on the frequency and pathogenesis of liver involvement in rheumatoid arthritis. Ann Rheum Dis. 1979;38:501.

    PubMed  CAS  Google Scholar 

  97. Weinblatt ME, Tesser JRP, Gilliam JH. The liver in rheumatic diseases. Semin Arthritis Rheum. 1981;11:399.

    Google Scholar 

  98. Mogadam M, Schuman B, Duncan H, et al. Necrotizing colitis associated with rheumatoid arthritis. Gastroenterology. 1969;57:168.

    PubMed  CAS  Google Scholar 

  99. Pettersson T, Wegelius D, Skrifvars B. Gastrointestinal disturbances in patients with severe rheumatoid arthritis. Acta Med Scand. 1970;188:139.

    Google Scholar 

  100. Atwater EC, Morgan ES, Wieche DR, et al. Peptic ulcer and rheumatoid arthritis: a prospective study. Arch Intern Med. 1965;115:184.

    PubMed  CAS  Google Scholar 

  101. Brun C, Olsen TX, Rasshou F, et al. Renal biopsy in rheumatoid arthritis. Nephron. 1965;2:65.

    PubMed  CAS  Google Scholar 

  102. Healey LA, Bulger RJ. Abnormal renal function in rheumatoid arthritis. Arthritis Rheum. 1967;10:283.

    Google Scholar 

  103. Pollack VE, Priani CL, Steck IE, et al. The kidney in rheumatoid arthritis: studies by renal biopsy. Arthritis Rheum. 1962;5:1.

    Google Scholar 

  104. Lawson AAH, MacLean N. Renal disease and drug therapy in rheumatoid arthritis. Ann Rheum Dis. 1966;25:441.

    PubMed  CAS  Google Scholar 

  105. Samuels B, Lee JC, Engleman EP, Hooper Jr J. Membranous nephropathy in patients with rheumatoid arthritis: relationship to gold therapy. Medicine. 1977;57:319.

    Google Scholar 

  106. O’Driscoll S, O’Driscoll M. Osteomalacia in rheumatoid arthritis. Ann Rheum Dis. 1980;39:1.

    PubMed  Google Scholar 

  107. Williamson J. Incidence of eye disease in cases of connective tissue disease. Trans Ophthalmol Soc UK. 1974;94:742.

    PubMed  CAS  Google Scholar 

  108. Thompson M, Eadie S. Keratoconjunctivitis sicca and rheumatoid arthritis. Ann Rheum Dis. 1956;5:21.

    Google Scholar 

  109. Lackington MC, Charlin VC, Gormas BA. Keratoconjunctivitis sicca y artritis reumatoidea. Rev Med Chil. 1951;79:133.

    Google Scholar 

  110. Lamberts DW. Dry eye and tear deficiency. Int Ophthalmol Clin. 1983;23(1):123.

    PubMed  CAS  Google Scholar 

  111. Ichikawa Y, Takaya M, Saitoh H. Characterization of sicca symptoms in patients with Sjögren’s syndrome, and report of six cases lacking subjective sicca features (“subclinical syndrome”). Exp Clin Med. 1981;6:229.

    CAS  Google Scholar 

  112. von Grosz S. Aetiologie und therapy der Keratoconjunctivitis sicca. Klin Monatsbl Augenheilkund. 1936;97:472.

    Google Scholar 

  113. Sjögren H. Zur Kenntnis der Keratoconjunctivitis sicca (Keratitis filiformis bei Hypofunktion der Tränen drusen). Acta Ophthalmol. 1933;Suppl. 2:1.

    Google Scholar 

  114. McGavin DD, Williamson J, Forrester JV, et al. Episcleritis and scleritis: a study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol. 1976;60:192.

    PubMed  CAS  Google Scholar 

  115. Borel JF, Baumann G, Chapman I, et al. In vivo pharmacological effects of ciclosporin and some analogues. Adv Pharmacol. 1996;35:115–246.

    PubMed  CAS  Google Scholar 

  116. Brignole F, Pisella PJ, De Saint Jean M, Goldschild M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory makers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci. 2001;42:90–5.

    PubMed  CAS  Google Scholar 

  117. Strong B, Farley W, Stern ME, Pflugfelder SC. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea. 2005;24:80–5.

    PubMed  Google Scholar 

  118. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107:631–9.

    PubMed  CAS  Google Scholar 

  119. Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome dry eye with cyclosporine. Arch Ophthalmol. 2002;120:330–7.

    PubMed  CAS  Google Scholar 

  120. Latkany R. Dry eyes: etiology and management. Curr Opin Ophthalmol. 2008;19:287–91.

    PubMed  Google Scholar 

  121. Lyne AJ, Pitkeathley DA. Episcleritis and scleritis. Arch Ophthalmol. 1968;80:171.

    PubMed  CAS  Google Scholar 

  122. Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163.

    PubMed  CAS  Google Scholar 

  123. Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389.

    PubMed  CAS  Google Scholar 

  124. Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology. 1991;98:467.

    PubMed  CAS  Google Scholar 

  125. Jayson MIV, Jones DEP. Scleritis and rheumatoid arthritis. Ann Rheum Dis. 1971;30:343.

    PubMed  CAS  Google Scholar 

  126. Kleiner RC, Raber IM, Passero FC. Scleritis, pericarditis, and aortic insufficiency in a patient with rheumatoid arthritis. Ophthalmol.1984;91:941.

    Google Scholar 

  127. Sevel D. Rheumatoid nodule of the sclera. (A type of necrogranulomatous scleritis). Trans Ophthalmol Soc UK. 1965;85:357.

    PubMed  CAS  Google Scholar 

  128. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with rheumatoid artritis and with other systemic immune-mediated diseases. Ophthalmology. 1994;101:1281.

    PubMed  CAS  Google Scholar 

  129. Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Ophthalmology. 1984;91:1253.

    PubMed  CAS  Google Scholar 

  130. Smoleroff JW. Scleral disease in rheumatoid arthritis; report of three cases, in one of which both eyes were studied post mortem. Arch Ophthalmol. 1943;29:98.

    Google Scholar 

  131. Hurd ER, Snyder WB, Ziff M. Choroidal nodules and retinal detachments in rheumatoid arthritis. Am J Med. 1970;48:273.

    PubMed  CAS  Google Scholar 

  132. Lachman SM, Hazleman BL, Watson PG. Scleritis and associated disease. Br Med J. 1978;1:88.

    Google Scholar 

  133. Brown SI, Grayson M. Marginal furrows: a characteristic corneal lesion of rheumatoid arthritis. Arch Ophthalmol. 1968;79:563.

    PubMed  CAS  Google Scholar 

  134. Eiferman RA, Carothers DJ, Yankeelov JA. Peripheral rheumatoid ulceration and evidence for conjunctival collagenase production. Am J Ophthalmol. 1979;87:703.

    PubMed  CAS  Google Scholar 

  135. Jayson MIV, Easty DL. Ulceration of the cornea in rheumatoid arthritis. Ann Rheum Dis. 1977;36:428.

    PubMed  CAS  Google Scholar 

  136. Scharf Y, Meyer E, Nahir M, Zonis S. Marginal mottling of cornea in rheumatoid arthritis. Ann Ophthalmol. 1984;16:924.

    PubMed  CAS  Google Scholar 

  137. Lyne AJ. “Contact lens” cornea in rheumatoid arthritis. Br J Ophthalmol. 1970;54:410.

    PubMed  CAS  Google Scholar 

  138. Sainz de la Maza M, Foster CS. The diagnosis and treatment of peripheral ulcerative keratitis. Semin Ophthalmol. 1991;6(3):133.

    Google Scholar 

  139. Tauber J, Sainz de la Maza M, Hoang-Xuan T, Foster CS. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea. 1990;9(1):66.

    PubMed  CAS  Google Scholar 

  140. Kimura SJ, Hogan MJ, O’Connor GR, et al. Uveitis and joint diseases. Arch Ophthalmol. 1967;77:309.

    PubMed  CAS  Google Scholar 

  141. Meyer E, Scharf J, Miller B, et al. Fundus lesions in rheumatoid arthritis. Ann Ophthalmol. 1978; 10:1583.

    PubMed  CAS  Google Scholar 

  142. Martin M, Scott D, Gilbert C, et al. Retinal vasculitis in rheumatoid arthritis. Br J Ophthalmol. 1981;282:1745.

    CAS  Google Scholar 

  143. Crompton J, Iyer P, Begg M. Vasculitis and ischemic optic neuropathy associated with rheumatoid arthritis. Aust J Ophthalmol. 1980;8:219.

    PubMed  CAS  Google Scholar 

  144. Killian PJ, McClain B, Lawless OJ. Brown’s syndrome: an unusual manifestation of rheumatoid arthritis. Arthritis Rheum. 1977;20:1080.

    PubMed  CAS  Google Scholar 

  145. Sandford-Smith JH. Intermittent superior oblique tendon sheath syndrome. Br J Ophthalmol. 1969;53:412.

    PubMed  CAS  Google Scholar 

  146. Watson P, Fekete J, Deck J. Central nervous system vasculitis in rheumatoid arthritis. Can J Neurol Sci. 1977;4:269.

    PubMed  CAS  Google Scholar 

  147. Ramos M, Mandybur TI. Cerebral vasculitis in rheumatoid arthritis. Arch Neurol. 1975;32:271.

    PubMed  CAS  Google Scholar 

  148. Victor DI, Green WR, Stark WJ, et al. A non-permanent tonic pupil in rheumatoid arthritis. Can J Neurol Sci. 1977;4:209.

    PubMed  CAS  Google Scholar 

  149. Edström G, Österlind G. A case of nodular rheumatic episcleritis. Acta Ophthalmol. 1948;26:1.

    Google Scholar 

  150. Mundy WL, Howard RY, Stillman PH, et al. Cortisone therapy in case of rheumatoid nodules of the eye in chronic rheumatoid arthritis. Arch Ophthalmol. 1951;45:531.

    CAS  Google Scholar 

  151. Fienberg R, Colpoys Jr FL. The involution of rheumatoid nodules treated with cortisone and of non-treated rheumatoid nodules. Am J Pathol. 1951;27:925.

    PubMed  CAS  Google Scholar 

  152. Ferry AP. The histopathology of rheumatoid episcleral nodules: an extra-articular manifestation of rheumatoid arthritis. Arch Ophthalmol. 1969;82:77.

    PubMed  CAS  Google Scholar 

  153. Leibowitz MA, Jakobiec FA, Donnenfeld ED, et al. Bilateral epibulbar rheumatoid nodulosis. A new ocular entity. Ophthalmology. 1988;95:1256.

    Google Scholar 

  154. Mesara BW, Brody GL, Oberman HA. “Pseudorheumatoid” subcutaneous nodules. Am J Clin Pathol. 1966;45:684.

    PubMed  CAS  Google Scholar 

  155. Rao NA, Font RL. Pseudorheumatoid nodules of the ocular anexa. Am J Ophthalmol. 1975;79:471.

    PubMed  CAS  Google Scholar 

  156. Ross MJ, Cohen KL, Peiffer Jr RL, et al. Episcleral and orbital pseudorheumatoid nodules. Arch Ophthalmol. 1983;101:418.

    PubMed  CAS  Google Scholar 

  157. Rose HM, Ragan C, Pearce E, et al. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med. 1948;68:1.

    PubMed  CAS  Google Scholar 

  158. Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand. 1940;17:172.

    CAS  Google Scholar 

  159. Tarkowski A, Czerkinsky C, Nilsson L-A. Simultaneous induction of rheumatoid factor-and antigen-specific antibody- secreting cells during the secondary immune response in man. Clin Exp Immunol. 1985;61:379.

    PubMed  CAS  Google Scholar 

  160. Aho K, Palosuo T, Raunio V, et al. When does rheumatoid disease start? Arthritis Rheum. 1985;28:485.

    PubMed  CAS  Google Scholar 

  161. Ball J, Lawrence JS. The relationship of rheumatoid serum factor to rheumatoid arthritis. Ann Rheum Dis. 1963;22:311.

    PubMed  CAS  Google Scholar 

  162. Del Puente A, Knowler WC, Pettit DJ, et al. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis Rheum. 1988;31:1239.

    PubMed  Google Scholar 

  163. Bland JH, Brown EW. Seronegative and seropositive rheumatoid arthritis: clinical, radiological, and ­biochemical differences. Ann Intern Med. 1964; 60:88.

    PubMed  CAS  Google Scholar 

  164. Kellgren JH, O’Brien WM. On the natural history of rheumatoid arthritis in relation to the sheep cell agglutination test (SCAT). Arthritis Rheum. 1962; 5:115.

    Google Scholar 

  165. Theofilopoulos AN, Burtonboy G, LoSpalluto JL, et al. IgM rheumatoid factor and low molecular weight IgM: an association with vasculitis. Arthritis Rheum. 1974;17:272.

    PubMed  CAS  Google Scholar 

  166. Engstedt L, Strandberg O. Haematological data and clinical activity of the rheumatoid diseases. Acta Med Scand. 1966;180:13.

    Google Scholar 

  167. Samson D, Holliday D, Gumpel JM. Role of ineffective erythropoiesis in the anaemia of rheumatoid arthritis. Ann Rheum Dis. 1977;36:181.

    PubMed  CAS  Google Scholar 

  168. Hutchinson RM, Davis P, Jayson MIV. Thrombocytosis in rheumatoid arthritis. Ann Rheum Dis. 1976;35:138.

    PubMed  CAS  Google Scholar 

  169. Winchester RJ, Litwin SD, Koffler D, et al. Observations on the eosinophilia of certain patients with rheumatoid arthritis. Arthritis Rheum. 1971;14:650.

    PubMed  CAS  Google Scholar 

  170. Panush RS, Franco AE, Schur PH. Rheumatoid arthritis associated with eosinophilia. Ann Intern Med. 1971;75:199.

    PubMed  CAS  Google Scholar 

  171. Fleming A, Crown JM, Corbett M. Prognostic value of early features in rheumatoid disease. Br Med J. 1976;1:1243.

    PubMed  CAS  Google Scholar 

  172. Amos RS, Constable TJ, Crockson RA, et al. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J. 1977;1:195.

    PubMed  CAS  Google Scholar 

  173. Nusinow S, Arnold WJ. Prognostic value of C-reactive protein (CRP) levels in rheumatoid arthritis. Clin Res. 1982;30:474.

    Google Scholar 

  174. Roth SH. Remission: the goal of rheumatic disease therapy. J Rheumatol. 1982;9(8):120.

    Google Scholar 

  175. Ruddy S, Austen KF. Activation of the complement system in rheumatoid synovitis. Fed Proc. 1973; 32:134.

    PubMed  CAS  Google Scholar 

  176. Jones VE, Jacoby RK, Wallington T, Holt P. Immune complexes in early arthritis. I. Detection of immune complexes before rheumatoid arthritis is definite. Clin Exp Immunol. 1981;44:512.

    PubMed  CAS  Google Scholar 

  177. Zubler RH, Nydegger UE, Perrin LH, et al. Circulating and intraarticular immune complexes in patients with rheumatoid arthritis. J Clin Invest. 1976;57:1308.

    PubMed  CAS  Google Scholar 

  178. Lessard J, Nunnery E, Cecere F, et al. Relationship between the articular manifestations of rheumatoid arthritis and circulating immune complexes detected by three methods and specific classes of rheumatoid factors. J Rheumatol. 1983;10:411.

    PubMed  CAS  Google Scholar 

  179. Fessel WJ. SLE in the community: incidence, prevalence, outcome and first symptoms; the high prevalence in black women. Arch Intern Med. 1974;134:1027.

    PubMed  CAS  Google Scholar 

  180. Siegel M, Lee SL. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum. 1973;3:1.

    PubMed  CAS  Google Scholar 

  181. Arnett FC, Shulman LE. Studies in familial systemic lupus erythematosus. Medicine. 1976;55:313.

    PubMed  CAS  Google Scholar 

  182. Winchester RJ, Nunez-Roldon A. Some genetic aspects of systemic lupus erythematosus. Arthritis Rheum. 1982;25:833.

    PubMed  CAS  Google Scholar 

  183. Hess EV. Introduction to drug related lupus. Kroc foundation conference on drug induced lupus. Arthritis Rheum. 1981;24:979.

    Google Scholar 

  184. Armas-Cruz R, Harnecker J, Ducach G, et al. Clinical diagnosis of systemic lupus erythematosus. Am J Med. 1958;25:409.

    Google Scholar 

  185. Davis P, Atkins B, Jesse RG, et al. Criteria for classification of SLE. Br Med J. 1973;3:88.

    PubMed  CAS  Google Scholar 

  186. Labowitz R, Schumacher HR. Articular manifestations of systemic lupus erythematosus. Ann Intern Med. 1971;74:911.

    PubMed  CAS  Google Scholar 

  187. Isbender DA, Snaith ML. Muscle disease in systemic lupus erythematosus: a study of its nature, frequency and cause. J Rheumatol. 1981;8:917.

    Google Scholar 

  188. Gilliam JN, Sontheimer OO. Skin manifestations of SLE. Clin Rheum Dis. 1982;8:207.

    PubMed  CAS  Google Scholar 

  189. Ropes MW. Systemic lupus erythematosus. Harvard University Press: Cambridge; 1976.

    Google Scholar 

  190. Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955–1977. Sem Artritis Rheum. 1979;8:212.

    CAS  Google Scholar 

  191. Pirani CL, Pollack VE. Systemic lupus erythematosus glomerulonephritis. In: Andres GA, McCluskey RT, editors. Immunologically mediated renal disease: criteria for diagnosis. New York: Dekkar; 1978.

    Google Scholar 

  192. Chia GL, Mah EPK, Feng PH. Cardiovascular abnormalities in systemic lupus erythematosus. J Clin Ultrasound. 1981;9:237.

    PubMed  CAS  Google Scholar 

  193. Bonfiglio TA, Botti RE, Hagstrom JWC. Coronary arteritis, occlusion and myocardial infarction due to lupus erythematosus. Am Heart J. 1972;83:153.

    PubMed  CAS  Google Scholar 

  194. Homcy CJ, Liberthson RR, Fallon JT, et al. Ischemic heart disease in systemic lupus erythematosus: report of six cases. Am J Cardiol. 1982;49:478.

    PubMed  CAS  Google Scholar 

  195. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med. 1924;33:701.

    Google Scholar 

  196. Buckley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med. 1975;58:243.

    Google Scholar 

  197. Feinglass EJ, Arnett FC, Dorsch CA, et al. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum and relationship to other features of the disease. Medicine. 1976;55:323.

    PubMed  CAS  Google Scholar 

  198. Klippel JH, Zwaifler NJ. Neuropsychiatric abnormalities in systemic lupus erythematosus. Clin Rheum Dis. 1975;1:621.

    Google Scholar 

  199. Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus: analysis of the pathologic changes in 120 patients. Am J Med. 1981;71:791.

    PubMed  CAS  Google Scholar 

  200. Matthay RA, Schwartz MI, Petty TL, et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine. 1974;54:397.

    Google Scholar 

  201. Runyon BA, LaBrecque DR, Anuras S. The spectrum of liver disease in systemic lupus erythematosus: report of 33 histologically proved cases and review of the literature. Am J Med. 1980;69:187.

    PubMed  CAS  Google Scholar 

  202. Dillon AM, Stein HB, English RA. Splenic atrophy in SLE. Ann Intern Med. 1982;96:40.

    PubMed  CAS  Google Scholar 

  203. Davies JB, Rao PK. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmolo. 2008;19:512.

    Google Scholar 

  204. Watson PG, Hazleman BL. The sclera and systemic disorders. W.B. Saunders Company: Philadelphia; 1976. p. 206–305.

    Google Scholar 

  205. Cappaert WE, Purnell EW, Frank KE. Use of B-sector scan ultrasound in the diagnosis of benign choroidal folds. Am J Ophthalmol. 1977;84:375.

    PubMed  CAS  Google Scholar 

  206. Gold DH, Morris DA, Henkind P. Ocular findings in systemic lupus erythematosus. Br J Ophthalmol. 1972;56:800.

    PubMed  CAS  Google Scholar 

  207. Larson DL. Systemic lupus erythematosus. Little Brown: Boston; 1961.

    Google Scholar 

  208. Harvey AM, Shulman LE, Tumulty PA, et al. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine. 1954;33:291.

    PubMed  CAS  Google Scholar 

  209. Frith P, Burge SM, Millard PR, et al. External ocular findings in lupus erythematosus: a clinical and immunopathological study. Br J Ophthalmol. 1990;74:163.

    PubMed  CAS  Google Scholar 

  210. Reeves JA. Keratopathy associated with systemic lupus erythematosus. Arch Ophthalmol. 1965;74:159.

    PubMed  CAS  Google Scholar 

  211. Henkind P, Gold DH. Ocular manifestations of rheumatic disorders: natural and iatrogenic. Rheumatology. 1973;4:13.

    PubMed  CAS  Google Scholar 

  212. Halmay O, Ludwig K. Bilateral bandshaped deep keratitis and iridocyclitis in systemic lupus erythematosus. Br J Ophthalmol. 1964;48:558.

    PubMed  CAS  Google Scholar 

  213. Spaeth GL. Corneal staining in systemic lupus erythematosus. N Engl J Med. 1967;276:1168.

    PubMed  CAS  Google Scholar 

  214. Heaton JM. Sjögren’s syndrome and systemic lupus erythematosus. Br Med J. 1959;1:466.

    PubMed  CAS  Google Scholar 

  215. Bencze G, Lakatos L. Relationship of systemic lupus erythematosus to rheumatoid arthritis, discoid lupus erythematosus, and Sjögren’s syndrome. Ann Rheum Dis. 1963;22:273.

    PubMed  CAS  Google Scholar 

  216. Dubois EL. The clinical picture of systemic lupus erythematosus. In: Dubois EL, editor. lupus erythematosus. New York: McGraw-Hill Book Co; 1966. p. 129–276.

    Google Scholar 

  217. Steinberg AD, Talal N. The coexistence of Sjögren’s syndrome and systemic lupus erythematosus. Ann Int Med. 1971;74:55.

    PubMed  CAS  Google Scholar 

  218. Brihaye-Van Geertruyden M, Danis P, Toussaint C. Fundus lesions with disseminated lupus. Arch Ophthalmol. 1954;51:799.

    CAS  Google Scholar 

  219. Maumenee AE. Retinal lesions in lupus erythematosus. Am J Ophthalmol. 1940;23:971.

    Google Scholar 

  220. Clifton F, Greer CH. Ocular changes in acute systemic lupus erythematosus. Br J Ophthalmol. 1955;39:1.

    PubMed  CAS  Google Scholar 

  221. Rothfield N. Clinical features of systemic lupus erythematosus. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of rheumatology. Philadelphia: WB Saunders Company; 1985. p. 1070–97.

    Google Scholar 

  222. Regan CDJ, Foster CS. Retinal vascular diseases: clinical presentation and diagnosis. Int Ophthalmol Clin. 1985;26:25.

    Google Scholar 

  223. Silberberg DH, Laties AM. Increased intracranial pressure in disseminated lupus erythematosus. Arch Neurol. 1973;29:88.

    PubMed  CAS  Google Scholar 

  224. Raptk L, Menard HA. Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest. 1980;66:1391.

    Google Scholar 

  225. Weinstein A, Bordwell B, Stone B, et al. Antibodies to native DNA and serum complement (C3) levels: applications to the diagnosis of systemic lupus erythematosus. Am J Med. 1983;74:206.

    PubMed  CAS  Google Scholar 

  226. Arnett FC. Seronegative spondylarthropathies. Bull Rheum Dis. 1987;37(1):1.

    PubMed  CAS  Google Scholar 

  227. Marks SH, Barnett M, Calin A. Ankylosing spondylitis in women and men: a case–control study. J Rheumatol. 1983;10:624.

    PubMed  CAS  Google Scholar 

  228. Woodrow JC. Genetic aspects of spondylarthropaties. Clin Rheum Dis. 1985;11:1.

    PubMed  CAS  Google Scholar 

  229. Brewerton DA, Caffrey M, Hart FD, et al. Ankylosing spondylitis and HL-A 27. Lancet. 1973;1:904.

    PubMed  CAS  Google Scholar 

  230. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361.

    PubMed  Google Scholar 

  231. Hunter T, Dubo H. Spinal fractures complicating ankylosing spondylitis. Ann Intern Med. 1978;88:546.

    PubMed  CAS  Google Scholar 

  232. Khan MA. Ankylosing spondylitis. In: Calin A, editor. Spondyloarthropathies. Orlando, FL: Grune & Stratton; 1984. p. 69–117.

    Google Scholar 

  233. Bergfeldt L, Moller E. Complete heart block-another HLA-B27 associated disease manifestation. Tissue Antigens. 1983;21:385.

    PubMed  CAS  Google Scholar 

  234. Bergfeldt L. HLA-B27 associated rheumatic diseases with severe cardiac bradyarrhythmias: clinical features and prevalence in 223 men with permanent pacemaker. Am J Med. 1983;75:210.

    PubMed  CAS  Google Scholar 

  235. Khan MA, Kushner I. Ankylosing spondylitis and multiple sclerosis: a possible association. Arthritis Rheum. 1979;22:784.

    PubMed  CAS  Google Scholar 

  236. Mason RM, Murray RS, Oates JK, et al. Prostatitis and ankylosing spondylitis. Rheum Phys Med. 1971;1:78.

    Google Scholar 

  237. Calin A. Renal glomerular function in ankylosing spondylitis. Scand J Rheumatol. 1975;4:241.

    PubMed  CAS  Google Scholar 

  238. Pasternack A, Tornroth T, Martio J. Ultrastructural studies of renal arteriolar changes in ankylosing spondylitis. Acta Pathol Microbiol Scand Sect A. 1971;79:591.

    CAS  Google Scholar 

  239. Jayson MIV, Salmon PR, Harrison W. Amyloidosis in ankylosing spondylitis. Rheum Phys Med. 1971;1:78.

    Google Scholar 

  240. Jennette JC, Ferguson AL, Moore MA, et al. IgA nephropathy associated with seronegative spondylarthropathies. Arthritis Rheum. 1982;25:144.

    PubMed  CAS  Google Scholar 

  241. Bluestone R. Ankylosing spondylitis. In: McCarthy DJ, editor. Arthritis and allied conditions. 10th ed. Philadelphia: Lea & Febiger; 1985. p. 819–40.

    Google Scholar 

  242. Hakin KN, Watson PG. Systemic associations of scleritis. In: Gold DH, editor. Systemic associations of ocular disorders. Int Ophthalmol Clin. 1991;31(3):111. Boston, Little: Brown and Company; 1991.

    Google Scholar 

  243. Rosenbaum JT, Theofilopoulos A, McDevitt HO, et al. Presence of circulating immune complexes in Reiter’s syndrome and ankylosing spondylitis. Clin Immun Pathol. 1981;18:291.

    CAS  Google Scholar 

  244. Keat AC. Reiter’s syndrome and reactive arthritis in perspective. N Engl J Med. 1983;309:1606.

    PubMed  CAS  Google Scholar 

  245. Moller G. Immunology of reactive arthritis and ankylosing spondylitis. Immunol Rev. 1985;86:1.

    Google Scholar 

  246. Reiter H. Ueber eine bisher unerkannte spirochaeteninfektion (spirochaetosis arthritica). Deut Med Wschr. 1916;42:1435.

    Google Scholar 

  247. Aho K, Leirisalo-Repo M, Reop H. Reactive arthritis. In: Panayi GS, editor. Seronegative spondyloarthropathies, vol. 11. London: Saunders; 1985. p. 25–40.

    Google Scholar 

  248. Winchester R, Bernstein DH, Fisher HD, et al. The co-occurrence of Reiter’s syndrome and acquired immunodeficiency. Ann Intern Med. 1987;106:19.

    PubMed  CAS  Google Scholar 

  249. Duvic M, Johnson TM, Rapini RP, et al. Acquired immunodeficiency syndrome-associated psoriasis and Reiter’s syndrome. Arch Dermatol. 1987;123:1622.

    PubMed  CAS  Google Scholar 

  250. Lin RY. Reiter’s syndrome and human immunodeficiency virus infection. Dermatologica. 1988;176:39.

    PubMed  CAS  Google Scholar 

  251. Carr JL, Friedman M. Keratodermia blennorrhagicum, report of a case with autopsy. Am J Pathol. 1944;20:709.

    PubMed  CAS  Google Scholar 

  252. Calin A. Spondyloarthropathies. Orlando, Fl: Grune & Stratton; 1984.

    Google Scholar 

  253. Buskila D, Langevitz P, Tenenbaum J, et al. Malar rash in a patient with Reiter’s syndrome – a clue for the diagnosis of human immunodeficiency virus infection. J Rheumatol. 1990;17:843.

    PubMed  CAS  Google Scholar 

  254. Lee DA, Barker SM, Daniel Su WP, et al. The clinical diagnosis of Reiter’s syndrome. Ophthalmology. 1986;93:350.

    PubMed  CAS  Google Scholar 

  255. Ostler HB, Dawson CR, Schachter J, et al. Reiter’s syndrome. Am J Ophthalmol. 1971;71:986.

    PubMed  CAS  Google Scholar 

  256. Weinberger HW, Ropes MW, Kulka JP, et al. Reiter’s syndrome, clinical and pathological observations: a lon-term study of 16 cases. Medicine. 1962;41:35.

    PubMed  CAS  Google Scholar 

  257. Zewi M. Morbus Reiteri. Acta Ophthalmol. 1947;25:47.

    CAS  Google Scholar 

  258. Mattson R. Recurrent retinitis in Reiter’s disease. Acta Ophthalmol. 1955;33:403.

    Google Scholar 

  259. Gerber LH, Espinoza LR. Psoriatic arthritis. Orlando, FL: Grune & Stratton; 1985.

    Google Scholar 

  260. Suarez-Almazor ME, Rusell AS. Sacroiliitis in psoriasis: relationship to peripheral arthritis and HLA-B27. J Rheumatol. 1990;17:804.

    Google Scholar 

  261. Bennet RM. Psoriatic arthritis. In: McCarthy DJ, editor. Arthritis and allied conditions. 11th ed. Philadelphia: Lea and Febiger; 1989. p. 954–71.

    Google Scholar 

  262. Gladman DD, Stafford-Brady F, Chang C, et al. Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol. 1990; 17:809.

    PubMed  CAS  Google Scholar 

  263. Leczinsky CG. The incidence of arthropathy in a ten-year series of psoriasis cases. Acta Derm Venereol. 1948;28:483.

    PubMed  CAS  Google Scholar 

  264. Little M, Harvie JN, Lester RS. Psoriatic arthritis in severe psoriasis. Can Med Assoc J. 1975;112:317.

    PubMed  CAS  Google Scholar 

  265. Roberts MET, Wright V, Hill AGS, et al. Psoriatic arthritis: a follow-up study. Ann Rheum Dis. 1976;35:206.

    PubMed  CAS  Google Scholar 

  266. Lambert JR, Wright V. Eye inflammation in psoriatic arthritis. Ann Rheum Dis. 1976;35:354.

    PubMed  CAS  Google Scholar 

  267. Bird HA, Wright V. Psoriatic arthritis. Clin Rheum Dis. 1983;9:671.

    PubMed  CAS  Google Scholar 

  268. Palumbo PJ, Ward LE, Sauer WG. Musculoskeletal manifestations of inflammatory bowel disease: ulcerative and granulomatous colitis and ulcerative proctitis. Mayo Clin Proc. 1973;48:411.

    PubMed  CAS  Google Scholar 

  269. Hopkins DJ, Horan E, Burton IL, et al. Ocular disorders in a series of 332 patients with Crohn’s disease. Br J Ophthalmol. 1974;58:732.

    PubMed  CAS  Google Scholar 

  270. Wright R, Lumsden K, Luntz MH, et al. Abnormalities of the sacroiliac joints and uveitis in ulcerative colitis. Quart J Med. 1965;34:229.

    PubMed  CAS  Google Scholar 

  271. Ernst BB, Lowder CY, Meisler D, et al. Posterior segment manifestations of inflammatory bowel disease. Ophthalmology. 1991;98:1272.

    PubMed  CAS  Google Scholar 

  272. Knox DL, Schachat AP, Mustonen E. Primary, secondary and coincidental ocular complications of Crohn’s disease. Ophthalmology. 1984;91:163.

    PubMed  CAS  Google Scholar 

  273. Yilmaz AE, Maden A, Unsal B. The prevalence of ocular involvement in patients with inflammatory bowel disease. Int J Colorectal Dis. 2007;22:1027.

    PubMed  Google Scholar 

  274. Salmon JF, Wright JP, Murray ADN. Ocular inflammation in Crohn’s disease. Ophthalmology. 1991;98:480.

    PubMed  CAS  Google Scholar 

  275. Mintz R, Feller ER, Bahr RL, Shah SA. Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:135.

    PubMed  Google Scholar 

  276. Petrelli EA, McKinley M, Troncale FJ. Ocular manifestations of inflammatory bowel disease. Ann Ophthalmol. 1982;14:356.

    PubMed  CAS  Google Scholar 

  277. Jameson Evans P, Eustace P. Scleromalacia perforans associated with Crohn’s disease. Br J Ophthalmol. 1973;57:330.

    Google Scholar 

  278. Knox DL, Snip RC, Stark WJ. The keratopathy of Crohn’s disease. Am J Ophthalmol. 1980;90:862.

    PubMed  CAS  Google Scholar 

  279. Clark RL, Muhletaler CA, Margulies SI. Colitic arthritis: clinical and radiographic manifestations. Radiol. 1971;101:585.

    CAS  Google Scholar 

  280. Jaksch-Wartenhorst R. Polychondropathia. Wien Arch Inn Med. 1923;6:93.

    Google Scholar 

  281. White JW. Relapsing polychondritis. Southern Med J. 1985;78:448.

    PubMed  Google Scholar 

  282. Isaak BL, Liesengang TJ, Michet Jr CJ. Ocular and systemic findings in relapsing polychondritis. Ophthalmology. 1986;93:681.

    PubMed  CAS  Google Scholar 

  283. Espinoza LR, Richman A, Bocanegra T, et al. Immune complex- mediated renal involvement in relapsing polychondritis. Am J Med. 1981;71:181.

    PubMed  CAS  Google Scholar 

  284. Sundaram MBM, Raiput AH. Nervous system complications of relapsing polychondritis. Neurology. 1983;33:513.

    PubMed  CAS  Google Scholar 

  285. Margargal LE, Donoso LA, Goldberg RE, et al. Ocular manifestations of relapsing polychondritis. Retina. 1981;1:96.

    Google Scholar 

  286. McKay DAR, Watson PG, Lyne AJ. Relapsing polychondritis and eye disease. Br J Ophthalmol. 1974;58:600.

    PubMed  CAS  Google Scholar 

  287. Matoba A, Plager S, Barger J, et al. Keratitis in relapsing polychondritis. Ann Ophthalmol. 1984;16:367.

    PubMed  CAS  Google Scholar 

  288. Chow MT, Anderson SF. Relapsing polychondritis. Optom Vis Sci. 2000;77:286.

    PubMed  CAS  Google Scholar 

  289. Michelson JB. Melting corneas with collapsing nose. Surv Ophthalmol. 1984;29:148.

    PubMed  CAS  Google Scholar 

  290. Hoangh-Xuan T, Foster CS, Rice BA. Scleritis in relapsing polychondritis. Response to therapy. Ophthalmology. 1990;97:892.

    Google Scholar 

  291. McAdam LP, O’Hanlan MA, Bluestone R, et al. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine. 1976;55:193.

    PubMed  CAS  Google Scholar 

  292. Damiani JM, Levine HL. Relapsing polychondritis-report of ten cases. Laryngoscope. 1979;89:929.

    PubMed  CAS  Google Scholar 

  293. Kussmaul A, Maier K. Über eine bischer nicht beschreibene eigenthümliche Arterienerkrankung (periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Müskellähmung einhergeht. Dtsch Arch Klin Med. 1866;1:484.

    Google Scholar 

  294. Zeek PM. Periarteritis nodosa and other forms of necrotizing angiitis. N Engl J Med. 1953;18:764.

    Google Scholar 

  295. Lieb ES, Restivo C, Paulus HE. Immunosuppressive and corticosteroid therapy for polyarteritis nodosa. Am J Med. 1979;67:941.

    Google Scholar 

  296. Kurland LT, Chuang TY, Hunder GG. The epidemiology of systemic arteritis. In: Laurence RE, Shulman LE, editors. Current topics in rheumatology: epidemiology of the rheumatic diseases. New York: Gower Medical Publisher, Ltd; 1984. p. 196–205.

    Google Scholar 

  297. Cupps TR, Fauci AS. The vasculitides. Philadelphia: W.B. Saunders Company; 1981.

    Google Scholar 

  298. Cohen RD, Conn DL, Ilstrup DM. Clinical features, prognosis, and response to treatment in polyarteritis. Mayo Clin Proc. 1980;55:146.

    PubMed  CAS  Google Scholar 

  299. Goldstein I, Wexler D. The ocular pathology of periarteritis nodosa. Arch Ophthalmol. 1929;2:288.

    Google Scholar 

  300. Friedenwald JS, Rones B. Ocular lesions in septicemia. Arch Ophthalmol. 1931;5:175.

    Google Scholar 

  301. Gaynon IE, Asbury MK. Ocular findings in a case of periarteritis nodosa. Am J Ophthalmol. 1943; 23:1072.

    Google Scholar 

  302. Goldsmith J. Periarteritis nodosa with involvement of the choroidal and retinal arteries. Am J Ophthalmol. 1946;29:435.

    PubMed  CAS  Google Scholar 

  303. Goar EL, Smith LS. Polyarteritis nodosa of the eye. Am J Ophthalmol. 1952;35:1619.

    PubMed  CAS  Google Scholar 

  304. Sheehan B, Harriman DG, Bradshaw JP. Polyarteritis nodosa with ophthalmic and neurological complications. Arch Ophthalmol. 1958;60:537.

    CAS  Google Scholar 

  305. King RT. Ocular involvement in a case of periarteritis nodosa. Trans Ophthalmol Soc UK. 1935;55:246.

    Google Scholar 

  306. Ford RG, Siekert RG. Central nervous system manifestations of periarteritis nodosa. Neurology. 1965; 15:114.

    PubMed  CAS  Google Scholar 

  307. Kimbrell Jr OC, Wheliss JA. Polyarteritis nodosa complicated by bilateral optic neuropathy. JAMA. 1967;201:61.

    Google Scholar 

  308. Van Wien S, Merz EH. Exophthalmos secondary to periarteritis nodosa. Am J Ophthalmol. 1963;56:204.

    Google Scholar 

  309. Purcell Jr JJ, Birkenkamp R, Tsai CC. Conjunctival lesions in periarteritis nodosa, a clinical and immunopathologic study. Arch Ophthalmol. 1984;102:736.

    PubMed  Google Scholar 

  310. Harbert F, McPherson SD. Scleral necrosis in periarteritis nodosa. Am J Ophthalmol. 1947;30:727.

    PubMed  CAS  Google Scholar 

  311. Wise GN. Ocular periarteritis nodosa. AMA Arch Ophthalmol. 1952;48:1.

    PubMed  CAS  Google Scholar 

  312. Cogan DG. Corneoscleral lesions in periarteritis nodosa and Wegener’s granulomatosis. Trans Am Acad Ophthalmol. 1955;53:321.

    CAS  Google Scholar 

  313. Moore JG, Sevel D. Corneoscleral ulceration in periarteritis nodosa. Br J Ophthalmol. 1966;50:651.

    PubMed  CAS  Google Scholar 

  314. Longstreth PL, Lorobkin M, Palubinskas AJ. Renal microaneurysms in a patient with systemic lupus erythematosus. Radiology. 1974;113:65.

    PubMed  CAS  Google Scholar 

  315. McKusick VA. Buerger’s disease: a distinct clinical and pathologic entity. JAMA. 1962;181:93.

    Google Scholar 

  316. Diaz-Perez JL, Winkelmann RK. Cutaneous periarteritis nodosa. Arch Dermatol. 1974;110:407.

    PubMed  CAS  Google Scholar 

  317. Sack M, Cassidy JT, Bole GG. Prognostic factors in polyarteritis. J Rheumatol. 1975;2:411.

    PubMed  CAS  Google Scholar 

  318. Dyck PJ, Conn DL, Okazaki H. Necrotizing angiopathic neuropathy: three-dimensional morphology of fiber degeneration related to sites of occluded vessels. Mayo Clin Proc. 1972;47:461.

    PubMed  CAS  Google Scholar 

  319. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol. 1951;27:277.

    PubMed  CAS  Google Scholar 

  320. Chumbley LC, Harrison Jr EG, Deremee RA. Allergic granulomatosis and angiitis (Churg–Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc. 1977;52:477.

    PubMed  CAS  Google Scholar 

  321. Lanham JG, Elkon KB, Pusey CD, et al. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg- Strauss syndrome. Medicine (Baltimore). 1984;63:65.

    CAS  Google Scholar 

  322. Nissim F, Von der Valde J, Czernobilsky B. A limited form of Churg–Strauss syndrome. Arch Pathol Lab Med. 1982;106:305.

    PubMed  CAS  Google Scholar 

  323. Cury D, Breakey AS, Payne BF. Allergic granulomatous angiitis associated with uveoscleritis and papilledema. Arch Ophthalmol. 1950;55:261.

    Google Scholar 

  324. Dicken CH, Winkelmann RK. The Churg–Strauss granuloma: cutaneous, necrotizing, palisading granuloma in vasculitis syndromes. Arch Pathol Lab Med. 1978;102:576.

    PubMed  CAS  Google Scholar 

  325. Strauss L, Churg J, Zak FG. Cutaneous lesions of allergic granulomatosis. A histopathologic study. J Invest Dermatol. 1951;17:349.

    PubMed  CAS  Google Scholar 

  326. Crotty CP, Deremee RA, Winkelmann RK. Cutaneous clinico-pathologic correlation of allergic granulomatosis. J Am Acad Dermatol. 1981;5:571.

    PubMed  CAS  Google Scholar 

  327. Wegener F. Über generalisierte, septische Gefässerkrankungen. Verh Dtsch Ges Pathol. 1936;29:202.

    Google Scholar 

  328. Wegener F. Über eine eigenartige rhinogene granulomatose mit besonderer Beteilingung des Arteriensystems und der Nieren. Beitr Pathol Anat Allg Pathol. 1939;102:36.

    Google Scholar 

  329. Godman GC, Churg J. Wegener’s granulomatosis: pathology and review of the literature. Arch Pathol. 1954;58:533.

    CAS  Google Scholar 

  330. Walton EW. Giant cell granuloma of the respiratory tract (Wegener’s granulomatosis). Br Med J. 1958; 2:265.

    PubMed  CAS  Google Scholar 

  331. Carrington CB, Leibow AA. Limited forms of angiitis and granulomatosis of Wegener’s type. Am J Med. 1966;41:497.

    PubMed  CAS  Google Scholar 

  332. Gross WL. Wegener’s granulomatosis. New aspects of the disease course, immunodiagnostic procedures, and stage-adapted treatment. Sarcoidosis. 1989; 6:15.

    PubMed  CAS  Google Scholar 

  333. Coutu RE, Klein M, Lessell S, et al. Limited form of Wegener granulomatosis. Eye involvement as a major sign. JAMA. 1975;233:868.

    PubMed  CAS  Google Scholar 

  334. Spalton DJ, Graham EM, Page NGR, Sanders MD. Ocular changes in limited forms of Wegener’s granulomatosis. Br J Ophthalmol. 1981;65:553.

    PubMed  CAS  Google Scholar 

  335. McDonald TJ, DeRemee RA. Wegener’s granulomatosis. Laryngoscope. 1983;93:220.

    PubMed  CAS  Google Scholar 

  336. DeRemee RA, McDonald TJ, Harrison EG, et al. Wegener’s granulomatosis. Anatomic correlates, a proposed classification. Mayo Clin Proc. 1976;51:777.

    PubMed  CAS  Google Scholar 

  337. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients over 21 years. Ann Intern Med. 1983;98:76.

    PubMed  CAS  Google Scholar 

  338. Soukasian SH, Jakobiek FA, Niles JL, Pavan-Langston D. Trimethoprim-Sulfamethoxazole for scleritis associated with limited Wegener´s granulomatosis: use of histopathology and anti-neutrophil cytoplasmic antibody (ANCA) test. Cornea. 1993;12:174.

    Google Scholar 

  339. Hall SL, Miller LC, Duggan E, et al. Wegener’s granulomatosis in pediatric patients. J Pediatr. 1985; 106:739.

    PubMed  CAS  Google Scholar 

  340. Nölle B, Specks U, Lüdemann J, et al. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener’s granulomatosis. Ann Intern Med. 1989;111:28.

    PubMed  Google Scholar 

  341. Pinching AJ, Lockwood CM, Pussell BA, et al. Wegener’s granulomatosis: observations on 18 patients with severe renal disease. Q J Med. 1983;52:435.

    PubMed  CAS  Google Scholar 

  342. Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener’s granulomatosis. Ophthalmology. 1983;90:279.

    PubMed  CAS  Google Scholar 

  343. Haynes BF, Fishman ML, Fauci AS, Wolff SM. The ocular manifestations of Wegener’s granulomatosis. Fifteen years experience and review of the literature. Am J Med. 1977;63:131.

    PubMed  CAS  Google Scholar 

  344. Tarabishy AB, Schulte M, Papaliodis GN, Hoffman GS. Wegener’s granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol. 2010;10:429.

    Google Scholar 

  345. Kinyoun JL, Kalina RE, Klein ML. Choroidal involvement in systemic necrotizing vasculitis. Arch Ophthalmol. 1987;105:939.

    PubMed  CAS  Google Scholar 

  346. Schmidt R, Koderisch J, Krastel H, et al. Sicca syndrome in patients with Wegener’s granulomatosis. Lancet. 1989;1:904.

    PubMed  CAS  Google Scholar 

  347. Leveille AS, Morse PH. Combined detachments in Wegener’s granulomatosis. Br J Ophthalmol. 1981;65:564.

    PubMed  CAS  Google Scholar 

  348. Brubacker R, Font RL, Shepherd EM. Granulomatous sclerouveitis. Regression of ocular lesions with cyclophosphamide and prednisone. Arch Ophthalmol. 1971;86:517.

    Google Scholar 

  349. Sacks RD, Stock EL, Crawford SE, et al. Scleritis and Wegener’s granulomatosis in children. Am J Ophthalmol. 1991;111:430.

    PubMed  CAS  Google Scholar 

  350. Kalina PH, Garrity JA, Herman DC, et al. Role of testing for anticytoplasmic autoantibodies in the differential diagnosis of scleritis and orbital pseudotumor. Mayo Clin Proc. 1990;65:1110.

    PubMed  CAS  Google Scholar 

  351. Charles SJ, Meyer PAR, Watson PG. Diagnosis and management of systemic Wegener’s granulomatosis presenting with anterior ocular inflammatory disease. Br J Ophthalmol. 1991;75:201.

    PubMed  CAS  Google Scholar 

  352. van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes; tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet. 1985;1:425.

    PubMed  Google Scholar 

  353. Ludemann G, Gross WL. Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener’s granulomatosis. Clin Exp Immunol. 1987;69:350.

    PubMed  CAS  Google Scholar 

  354. Savage CS, Winearls CG, Jones S, et al. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet. 1987;1:1389.

    PubMed  CAS  Google Scholar 

  355. Falk RJ, Jennette JC. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Eng J Med. 1988;318:1651.

    CAS  Google Scholar 

  356. Niles JL, McCluskey RT, Ahmad MF, et al. Wegener’s granulomatosis autoantigen is a novel neutrophil serine protease. Blood. 1989;74:1888.

    PubMed  CAS  Google Scholar 

  357. Jennette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol. 1989;135:921.

    PubMed  CAS  Google Scholar 

  358. Cohen Tervaert JW, Goldschmeding R, Elema JD, et al. Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum. 1990;33:1264.

    Google Scholar 

  359. Cohen Tervaert JW, Elema JD, Kallenberg CGM. Clinical and histopathological association of 29kD-ANCA and MPO-ANCA. APMIS. 1990;98(19):35.

    Google Scholar 

  360. Pulido JS, Goeken JA, Nerad JA, et al. Ocular manifestations of patients with circulating antineutrophil cytoplasmic antibodies. Arch Ophthalmol. 1990;108:845.

    PubMed  CAS  Google Scholar 

  361. Soukiasian SH, Foster CS, Niles JL, Raizman MB. Diagnostic value of anti-neutrophil cytoplasmic antibodies (ANCA) in scleritis associated with Wegener’s granulomatosis. Ophthalmology. 1992;99:125.

    PubMed  CAS  Google Scholar 

  362. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of WG. Arthritis Rheum. 1990;33:1101.

    PubMed  CAS  Google Scholar 

  363. Feigenbaum A. Description of Behçet’s syndrome in the hippocratic third book of endemic diseases. Br J Ophthalmol. 1956;40:355.

    PubMed  CAS  Google Scholar 

  364. Adamantiades B. Ann Ocul Paris. 1946;179:143.

    PubMed  CAS  Google Scholar 

  365. Behçet H. Ueber rezidivieerende, aphthose, durch ein Virus verursachte Geschwure am Mund, am Auge and an den Genitalien. Dermatol Wochenschr. 1937;105:1152.

    Google Scholar 

  366. Yamamoto S, Toyokawa H, Matsubara J, et al. A nation-wide survey of Behçet disease in Japan: 1. Epidemiological survey. Jpn J Ophthalmol. 1974; 18:282.

    Google Scholar 

  367. Foster CS, Baer JC, Raizman MB. Therapeutic responses to systemic immunosuppressive chemotherapy agents in patients with Behçet’s syndrome affecting the eyes. Rochester MN: Proc of the Fifth International Congress on Behçet’s Disease; 1989.

    Google Scholar 

  368. Atmaca LS. Fundus changes associated with Behçet’s disease. Graefe’s Arch Clin Exp Ophthalmol. 1989;227:340.

    CAS  Google Scholar 

  369. BenEzra D, Cohen E. Treatment and visual prognosis in Behçet’s disease. Brit J Ophthalmol. 1986;70:589.

    CAS  Google Scholar 

  370. Mishima S, Masuda K, Izawa Y, et al. Behçet’s disease in Japan: ophthalmological aspects. Trans Am Ophthalmol Soc. 1979;77:225.

    PubMed  CAS  Google Scholar 

  371. Colvard DM, Robertson DM, O’Duffy JD. The ocular manifestations of Behçet’s disease. Arch Ophthalmol. 1977;95:1813.

    PubMed  CAS  Google Scholar 

  372. Yazici H, Chamberlain MA, Schreuder I, et al. HLA antigens in Behçet’s disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis. 1980;39:344.

    PubMed  CAS  Google Scholar 

  373. O’Duffy JD, Taswell HF, Elvebeck LR. HL-A antigens in Behçet’s disease. J Rheumatol. 1976;3:1.

    PubMed  Google Scholar 

  374. Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA- Bw51 with Behçet’s disease. Arch Ophthalmol. 1982;100:1455.

    PubMed  CAS  Google Scholar 

  375. Baricordi OR, Sensi A, Pivetti-Pezzi P, et al. Behçet’s disease associated with HLA-B51 and DRw52 antigens in italians. Hum Immunol. 1986;17:297.

    PubMed  CAS  Google Scholar 

  376. Davies PG, Fordham JN, Kirwan JR, et al. The pathergy test and Behçet’s syndrome in Britain. Ann Rheum Dis. 1984;43:70.

    PubMed  CAS  Google Scholar 

  377. James DG, Spiteri MA. Behçet’s disease. Ophthalmology. 1982;89:1279.

    PubMed  CAS  Google Scholar 

  378. O’Duffy JD. Suggested criteria for the diagnosis of Behçet’s disease. J Rheumatol. 1974;1(1):18.

    Google Scholar 

  379. Wechsler B, Davatchi F, Mizushima Y, (International Study Group for Behçet’s disease), et al. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335:1078.

    Google Scholar 

  380. Wilkinson IMS, Russell RWR. Arteries of the head and neck in giant cell arteritis. Arch Neurol. 1972; 27:378.

    PubMed  CAS  Google Scholar 

  381. Klein RG, Hunder GG, Stanson AW, et al. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med. 1975;83:806.

    PubMed  CAS  Google Scholar 

  382. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:8.

    Google Scholar 

  383. Paraskevas KT, Boumpas DT, Vrentzos GE, Mikhailidis DP. Oral and ocular/orbital manifestations of temporal arteritis: a disease with deceptive clinical symptoms and devastating consequences. Clin Rheumatol. 2007;26:1044.

    PubMed  Google Scholar 

  384. Friedman G, Friedman B, Benbassat J. Epidemiology of temporal arteritis in Israel. Isr J Med Sci. 1982;18:241.

    PubMed  CAS  Google Scholar 

  385. Machado EBV, Michet C, Ballard DJ, et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950–1985. Athritis Rheum. 1988;31:745.

    CAS  Google Scholar 

  386. Hazleman B, Goldstone A, Voak D. Association of polymyalgia rheumatica and giant-cell arteritis with HLA-B8. Br Med J. 1977;2:989.

    PubMed  CAS  Google Scholar 

  387. Barrier J, Bignon JD, Soulillou JP, et al. Increase prevalence of HLA-DR4 in giant-cell arteritis (letter). NEJM. 1981;305:104.

    PubMed  CAS  Google Scholar 

  388. Malmvall B, Bentsson B, Rydberg L. HLA antigens in patients with giant cell arteritis, compared with two control groups of different ages. Scand J Rheumatol. 1980;9:65.

    PubMed  CAS  Google Scholar 

  389. Hunder GG, Taswell HF, Pineda AA, et al. HLA antigens in patients with giant cell arteritis and polymyalgia rheumatica. J Rheumatol. 1977;4:321.

    PubMed  CAS  Google Scholar 

  390. Huston KA, Hunder GG, Lie JT, et al. Temporal arteritis. A 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978;89:162.

    Google Scholar 

  391. Whitfield AGW, Bateman M, Trevor-Cooke W. Temporal arteritis. Br J Ophthalmol. 1963;47:555.

    PubMed  CAS  Google Scholar 

  392. Hunder GG. Giant cell (temporal) arteritis. Rheum Dis Clin N Am. 1990;16:399.

    CAS  Google Scholar 

  393. Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology. 1988;38:352.

    PubMed  CAS  Google Scholar 

  394. Reich KA, Giansiracusa DF, Strongwater SL. Neurologic manifestations of giant cell arteritis. Am J Med. 1990;89:67.

    PubMed  CAS  Google Scholar 

  395. Cohen MD, Ginsburg WW. Polymyalgia rheumatica. Rheum Dis Clin of N Am. 1990;16:325.

    CAS  Google Scholar 

  396. Hunder GG, Allen GL. Giant cell arteritis: a review. Bull Rheum Dis. 1978–79;29:980.

    Google Scholar 

  397. Chuang T, Hunder GG, Ilstrup DM, et al. Polymyalgia rheumatica. A 10-year epidemiological and clinical study. Ann Intern Med. 1982;97:672.

    PubMed  CAS  Google Scholar 

  398. Rynes RI, Mika P, Bartholomew LE. Development of giant cell (temporal) arteritis in a patient “adequately” treated for polymyalgia rheumatica. Ann Rheum Dis. 1977;36:88.

    PubMed  CAS  Google Scholar 

  399. Birkhead NC, Wagener HP, Shick RM. Treatment of temporal arteritis with adrenal corticosteroids: results in 55 cases in which the lesion was proved at biopsy. JAMA. 1975;163:821.

    Google Scholar 

  400. Hollenhorst RW, Brown JR, Wagener HP, et al. Neurologic aspects of temporal arteritis. Neurology. 1960;10:490.

    PubMed  CAS  Google Scholar 

  401. Graham E, Holland A, Avery A, et al. Prognosis in giant-cell arteritis. Br Med J. 1981;282:269.

    CAS  Google Scholar 

  402. Hayreh HH. Anterior ischemic optic neuropathy. Differentiation of arteritis from non-arteritic type and its management. Eye. 1990;4:25.

    PubMed  Google Scholar 

  403. Daiker B, Keller HH. Riesenallarteriitis mit endookulärer Ausbreitung und Hypotonia bulbi dolorosa. Klin Monatsbl Augenheilkund. 1971;158:358.

    Google Scholar 

  404. Wong RL, Korn JH. Temporal arteritis without an elevated erythrocyte sedimentation rate. Am J Med. 1986;80:959.

    PubMed  CAS  Google Scholar 

  405. Andersson R, Malmvall B, Bengtsson B. Acute phase reactants in the initial phase of giant cell arteritis. Acta Med Scand. 1986;220:365.

    PubMed  CAS  Google Scholar 

  406. Kyle V, Cawston TE, Hazleman BL. Erythocyte sedimentation rate and C reactive protein in the assissment of polymyalgia rheumatica/giant cell arteritis on presentation and during followup. Ann Rheum Dis. 1989;48:667.

    PubMed  CAS  Google Scholar 

  407. Desmet GD, Knockaert DC, Bobbaers HJ. Temporal arteritis: the silent presentation and delay in diagnosis. J Int Med. 1990;227:237.

    CAS  Google Scholar 

  408. Dasgupta B, Duke O, Timms AM, et al. Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis. 1989;48:307.

    PubMed  CAS  Google Scholar 

  409. Hall S, Hunder GG. Is temporal artery biopsy prudent? Mayo Clin Proc. 1984;59:793.

    PubMed  CAS  Google Scholar 

  410. Albert DM, Ruchman MC, Keltner JL. Skip areas in temporal arteritis. Arch Ophthalmol. 1979;94:2072.

    Google Scholar 

  411. Allison MC, Gallagher PJ. Temporal artery biopsy and corticosteroid treatment. Ann Rheum Dis. 1984;43:416.

    PubMed  CAS  Google Scholar 

  412. Hedges TR, Geiger GL, Albert DM. The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol. 1983;101:1251.

    PubMed  Google Scholar 

  413. Hall S, Lie JT, Kurland LT, et al. The therapeutic impact of temporal artery biopsy. Lancet. 1983;2:1217.

    PubMed  CAS  Google Scholar 

  414. Cogan DG. Syndrome of nonsyphilitic interstitial keratitis with vestibuloauditory symptoms. Arch Ophthalmol. 1945;33:144.

    Google Scholar 

  415. Cogan DG. Nonsyphilitic keratitis and vestibuloauditory symptoms: four additional cases. Arch Ophthalmol. 1949;42:42.

    CAS  Google Scholar 

  416. Cobo LM, Haynes BF. Early corneal findings in Cogan’s syndrome. Ophthalmology. 1980;91:903.

    Google Scholar 

  417. Norton EW, Cogan DG. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol. 1959;61:695.

    CAS  Google Scholar 

  418. Roberts J. Cogan’s syndrome. Med J Aust. 1965;1:186.

    PubMed  CAS  Google Scholar 

  419. Cheson BD. Cogan´s syndrome. Clin Adv Hematol Oncol. 2010;8:833.

    PubMed  Google Scholar 

  420. Cogan DG, Dickerson GR. Nonsyphilitic interstitial keratitis with vestibuloauditory syndrome: a case with fatal aortitis. Arch Ophthalmol. 1964;71:172.

    PubMed  CAS  Google Scholar 

  421. Haynes BF, Kaiser-Kupfer MI, Mason P, et al. Cogan’s syndrome: studies in thirteen patients, long-term followup, and a review of the literature. Medicine. 1980;59:426.

    PubMed  CAS  Google Scholar 

  422. Eisenstein B, Taubenhaus M. Nonsyphilitic interstitial keratitis and bilateral deafness (Cogan’s syndrome) associated with cardiovascular disease. N Engl J Med. 1958;258:1074.

    PubMed  CAS  Google Scholar 

  423. Fisher ER, Hellstrom HR. Cogan’s syndrome and systemic vascular disease. Arch Pathol. 1961;72:572.

    PubMed  CAS  Google Scholar 

  424. Gelfand ML, Kantor T, Gorstein F. Cogan’s syndrome with cardiovascular involvement; aortic insufficiency. Bull NY Acad Med. 1972;48:647.

    CAS  Google Scholar 

  425. Haynes BF, Pikus A, Kaiser-Kupfer MI, et al. Successful treatment of sudden hearing loss in Cogan’s syndrome with corticosteroids. Arthritis Rheum. 1981;24:501.

    PubMed  CAS  Google Scholar 

  426. Bennet FM. Bilateral recurrent episcleritis associated with posterior corneal changes, vestibulo-auditory symptoms and rheumatoid arthritis. Am J Ophthalmol. 1963;55:815.

    Google Scholar 

  427. Watson PG. Management of scleral disease. Trans Ophthalmol Soc UK. 1966;86:151.

    PubMed  CAS  Google Scholar 

  428. Gilbert WS, Talbot FJ. Cogan’s syndrome. Signs of periarteritis nodosa and cerebral venous sinus thrombosis. Arch Ophthalmol. 1969;82:633.

    PubMed  CAS  Google Scholar 

  429. Holt-Wilson AD, Watson PG. Nonsyphilitic deep interstitial keratitis associated with scleritis. Trans Ophthalmol Soc UK. 1974;94:52.

    Google Scholar 

  430. Hedges TR, Taylor GW. Uveal and vestibulo-auditory disease with sarcoid. Arch Ophthalmol. 1952;48:88.

    CAS  Google Scholar 

  431. McGavin DDM, McNeill J. Scleritis and perceptive deafness: case report. Ann Ophthalmol. 1979;48:1287.

    Google Scholar 

  432. Coca AF, Cooke RA. On the classification of the phenomena of hypersensitiveness. J Immunol. 1923;8:163.

    CAS  Google Scholar 

  433. Duke-Elder S, Leigh AG. Diseases of the outer eye, cornea and sclera. In: Duke-Elder S, editor. System of ophthalmology, vol 8, pt 2. St Louis: CV Mosby Co; 1965.

    Google Scholar 

  434. Braude LS, Chandler JW. Atopic corneal disease. Int Ophthalmol Clin. 1984;24(2):145.

    PubMed  CAS  Google Scholar 

  435. Buckley RJ. Atopic disease of the cornea. In: Cavanagh HD, editor. The cornea: transactions of the world congress of the cornea III. New York: Raven Press; 1988. p. 435–7.

    Google Scholar 

  436. Cassidy JT, Levinson JE, Bass JC, et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum. 1986;29:274.

    PubMed  CAS  Google Scholar 

  437. Kanski JJ. Juvenile arthritis and uveitis. Surv Ophthalmol. 1990;34:253.

    PubMed  CAS  Google Scholar 

  438. Lyne AJ, Rosen ES. Still’s disease and rheumatoid nodules of the sclera. Br J Ophthalmol. 1968; 52:853.

    PubMed  CAS  Google Scholar 

  439. Watson P. Diseases of the sclera and episclera. In: Duane TD, Jaeger EA, editors. Clinical ophthalmology, vol 4, chap 23. Philadelphia: Harper and Row; 1985.

    Google Scholar 

  440. Ide T, Inoue K. Case of unilateral episcleral sarcoid tubercle. Folia Ophthalmol Jpn. 1968;19:632.

    CAS  Google Scholar 

  441. James DG, Anderson R, Langley D, et al. Ocular sarcoidosis. Br J Ophthalmol. 1964;48:461.

    PubMed  CAS  Google Scholar 

  442. Friedman AH, Henkind P. Unusual cases of episcleritis. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:890.

    Google Scholar 

  443. Klein M, Calvert RJ, Joseph WE, et al. Rarities in ocular sarcoidosis. Br J Ophthalmol. 1955;39:416.

    PubMed  CAS  Google Scholar 

  444. Donaldson DD. Sarcoid nodules of iris and of paralimbal sclera. Arch Ophthalmol. 1964;71:246.

    Google Scholar 

  445. Zeiter JH, Bhavsar A, McDermott ML, et al. Ocular sarcoidosis manifesting as an anterior staphyloma. Am J Ophthalmol. 1991;112:3.

    Google Scholar 

  446. Tabbara KF. Scleromalacia associated with Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol. 1988;105:6.

    Google Scholar 

  447. Mackensen F, Smith JR, Rosenbaum JT. Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology. 2007;114:995.

    PubMed  Google Scholar 

  448. Daniel E, Gangaputra S, Kempen JH, et al. Recurrent nodular scleritis preceding and adult TINU syndrome. Ocul Immunol Inflamm. 2006;14:239.

    PubMed  Google Scholar 

  449. Sainz de la Maza M, Foster CS. Necrotizing scleritis after ocular surgery: a clinicopathologic study. Ophthalmology. 1991;98:1720.

    PubMed  CAS  Google Scholar 

  450. Insler MS, Boutros G, Boulware DW. Corneal ulceration following cataract surgery in patients with rheumatoid arthritis. Am Intraocular Implant Soc J. 1985;11:594.

    CAS  Google Scholar 

  451. Bloomfield SE, Becker CG, Christian CL, Nauheim JS. Bilateral necrotising scleritis with marginal corneal ulceration after cataract surgery in a patient with vasculitis. Br J Ophthalmol. 1980;64:170.

    PubMed  CAS  Google Scholar 

  452. Rao NA, Marak GE, Hidayat AA. Necrotizing scleritis. A clinico-pathologic study of 41 cases. Ophthalmology. 1985;92:1542.

    PubMed  CAS  Google Scholar 

  453. Collins DH. The subcutaneous nodule of rheumatoid arthritis. J Pathol Bacteriol. 1937;45:97.

    Google Scholar 

  454. Bennett GA, Zeller JW, Bauer W. Subcutaneous nodules of rheumatoid arthritis and rheumatic fever: a pathologic study. Arch Pathol. 1940;30:70.

    Google Scholar 

  455. Kaye BR, Kaye RL, Bobrove A. Rheumatoid nodules. Review of the spectrum of associated conditions and proposal of a new classification, with a report of four seronegative cases. Am Rheum Dis. 1964;23:345.

    Google Scholar 

  456. Soter NA, Austen KF. Cutaneous necrotizing angiitis. In: Samter M, et al., editors. Immunological diseases. Boston: Little, Brown & Company; 1978.

    Google Scholar 

  457. McDuffee FD, Sams Jr WM, Maldonado JE. Hypocomplementemia with cutaneous vasculitis and arthritis: possible immune complex syndrome. Mayo Clin Proc. 1973;48:340.

    Google Scholar 

  458. Lyons CJ, Dart JKG, Aclimandos WA, et al. Sclerokeratitis after keratoplasty in atopy. Ophthalmology. 1990;97:729.

    PubMed  CAS  Google Scholar 

  459. Leo RJ, Palmer DJ. Episcleritis and secondary glaucoma after transcleral fixation of a posterior chamber intraocular lens. Arch Ophthalmol. 1991;109:617.

    Google Scholar 

  460. Browning DJ, Proia AD. Ocular rosacea. Sur Ophthalmol. 1986;31:145.

    CAS  Google Scholar 

  461. Osgood JK, Dougherty JM, McCulley JP. The role of wax and sterol esters of meibomian secretions in chronic blepharitis. Invest Ophthalmol Vis Sci. 1989;30:1958.

    PubMed  CAS  Google Scholar 

  462. Borrie P. Rosacea with special reference to its ocular manifestations. Br J Dermatol. 1953;65:458.

    PubMed  CAS  Google Scholar 

  463. Richter S. Skleraperforation bei Rosaceokeratitis. Klin Monatsbl Augenheilkd. 1965;146:422.

    PubMed  CAS  Google Scholar 

  464. Hoang-Xuan T, Rodriguez A, Zaltas MM, Rice BA, Foster CS. Ocular rosacea. A histologic and immunopathologic study. Ophthalmology. 1990; 97:1468.

    PubMed  CAS  Google Scholar 

  465. Scharf J, Nahir M, Sharf J. Scleritis associated with hyperuricaemia. Rheumato Tindall. 1975;14:251.

    CAS  Google Scholar 

  466. McWilliams JR. Ocular findings in gout. Am J Ophthalmol. 1952;35:1778.

    PubMed  CAS  Google Scholar 

  467. Wood DJ. Inflammatory disease in the eye caused by gout. Br J Ophthalmol. 1936;20:510.

    PubMed  CAS  Google Scholar 

  468. Heinz K. Ocular findings in cases of gout and ­hyperuricemia. Wien Klin Wochenschr. 1971;83:42.

    PubMed  CAS  Google Scholar 

  469. Fishman RS, Sunderman FW. Band keratopathy in gout. Arch Ophthalmol. 1966;75:367.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Institute of Ophthalmology, Hospital Clinic of Barcelona, Urgel 224, Barcelona, 08036, Spain

    Maite Sainz de la Maza MD, PhD (Clinical Associate Professor of Ophthalmology)

  2. Tauber Eye Center, 4400 Broadway, Suite 202, Kansas City, MO, 64111, USA

    Joseph Tauber MD

  3. Massachusetts Eye Research and Surgery Institution, Cambridge, MA, 02142, USA

    C. Stephen Foster MD (Professor of Ophthalmology Harvard Medical School)

Authors
  1. Maite Sainz de la Maza MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph Tauber MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Stephen Foster MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maite Sainz de la Maza MD, PhD .

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

de la Maza, M.S., Tauber, J., Foster, C.S. (2012). Noninfectious Scleritis. In: The Sclera. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-6502-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-6502-8_6

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-6501-1

  • Online ISBN: 978-1-4419-6502-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation